Top compounds associated with response to TRIM16L


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.067 0.2
mRNA bendamustine CTRPv2 pan-cancer AAC -0.048 0.2
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.053 0.2
mRNA Bortezomib gCSI pan-cancer AAC -0.083 0.2
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA VU0155056 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA NSC 74859 CTRPv2 pan-cancer AAC -0.048 0.2
mRNA tivantinib CTRPv2 pan-cancer AAC -0.055 0.2
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
Download CSV